May 11, 2022 / 06:20PM GMT
Derik De Bruin - BofA Securities, Research Division - MD of Equity Research
Welcome to Bank of America's 2022 Healthcare Conference live from Las Vegas. I'm Derik De Bruin, the senior life sciences and diagnostic tools analyst. And our next company is Myriad Genetics. And with us from Myriad is Paul Diaz, President and CEO. Paul, welcome. Thanks for being here.
Paul J. Diaz - Myriad Genetics, Inc. - CEO, President & Director
Great to be here. Thanks for the invitation.
Questions and Answers:
Derik De Bruin - BofA Securities, Research Division - MD of Equity ResearchSo Paul just to -- you're 2 years into the CEO role?
Paul J. Diaz - Myriad Genetics, Inc. - CEO, President & Director
Not quite.
Derik De Bruin - BofA Securities, Research Division - MD of Equity Research
Not quite 2 years in, yes. And I first picked up coverage of Myriad in 2001, right? So I've got -- been looking at this going to be a long time. I